What does GEASSOCIEERDE APOTHEEK EKEREN do?

GEASSOCIEERDE APOTHEEK EKEREN is a pharmacy in Antwerpen. Private Limited, started on 31 August 2001, 1 establishment.

What is the address of GEASSOCIEERDE APOTHEEK EKEREN?

The registered office of GEASSOCIEERDE APOTHEEK EKEREN is located at Dorpstraat 18, 2180 Antwerpen.

Is GEASSOCIEERDE APOTHEEK EKEREN still active?

Yes. According to the CBE (17 September 2026) GEASSOCIEERDE APOTHEEK EKEREN is active, legal situation “Normale toestand”, started on 31 August 2001.

Is GEASSOCIEERDE APOTHEEK EKEREN registered on Peppol?

Yes, GEASSOCIEERDE APOTHEEK EKEREN is registered on the Peppol network with ID 0208:0475537451.

What is the enterprise number of GEASSOCIEERDE APOTHEEK EKEREN?

The enterprise number of GEASSOCIEERDE APOTHEEK EKEREN is BE0475537451.

When was GEASSOCIEERDE APOTHEEK EKEREN founded?

GEASSOCIEERDE APOTHEEK EKEREN was founded on 31 August 2001.

Who are the directors of GEASSOCIEERDE APOTHEEK EKEREN?

According to the 2025 annual accounts, the directors of GEASSOCIEERDE APOTHEEK EKEREN are: A. Pirlot, J. Mannaerts.

Is GEASSOCIEERDE APOTHEEK EKEREN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 August 2001; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did GEASSOCIEERDE APOTHEEK EKEREN make in 2025?

GEASSOCIEERDE APOTHEEK EKEREN recorded a loss after taxes of € 20,030 in financial year 2025.

What is the revenue of GEASSOCIEERDE APOTHEEK EKEREN?

As a small company, GEASSOCIEERDE APOTHEEK EKEREN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 140,659.

How much does an employee at GEASSOCIEERDE APOTHEEK EKEREN earn?

The average wage cost per full-time employee at GEASSOCIEERDE APOTHEEK EKEREN was € 59,100 in 2025: staff costs of € 135,832 for 2.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does GEASSOCIEERDE APOTHEEK EKEREN have?

According to the 2025 annual accounts, GEASSOCIEERDE APOTHEEK EKEREN has 2.3 full-time equivalents (FTE).

Does GEASSOCIEERDE APOTHEEK EKEREN have a website?

Yes, GEASSOCIEERDE APOTHEEK EKEREN has a website at apotheeklaporte.be.

GEASSOCIEERDE APOTHEEK EKEREN (Private Limited)

Dossier GEASSOCIEERDE APOTHEEK EKEREN, printed on 17 September 2026 from databakkes.be/en/0475537451/geassocieerde-apotheek-ekeren. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

GEASSOCIEERDE APOTHEEK EKEREN from Antwerpen, company number BE0475537451, closed financial year 2025 with a result of € -20,030 after tax. For that financial year GEASSOCIEERDE APOTHEEK EKEREN recorded a gross margin of € 140,659 and equity of € 189,459. Compared with financial year 2024, the result moved from € -13,872 to € -20,030. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Healthy

€ 189,459

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -20,030

▼ 44 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,459

▲ 61% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 178,259.

People and assets in 2025

Full-time equivalents

2.3

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 135,832

▼ 3% vs 2024

€ 59,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 118,932

▲ 20% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 22,646

▼ 11% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 49,451 Gross margin 2022: € 49,451 First fiscal year in the series	€ 129,422 Gross margin 2023: € 129,422 ▲ 162% vs 2022 (€ 49,451) Favourable step	€ 155,860 Gross margin 2024: € 155,860 ▲ 20% vs 2023 (€ 129,422) Favourable step	€ 140,659 Gross margin 2025: € 140,659 ▼ 10% vs 2024 (€ 155,860) Unfavourable step	▼ 10%
Profit after taxes	€ -54,791 Profit after taxes 2022: € -54,791 First fiscal year in the series	€ -59,830 Profit after taxes 2023: € -59,830 ▼ € 5,039 vs 2022 (€ -54,791) Unfavourable step	€ -13,872 Profit after taxes 2024: € -13,872 ▲ € 45,957 vs 2023 (€ -59,830) Favourable step	€ -20,030 Profit after taxes 2025: € -20,030 ▼ € 6,157 vs 2024 (€ -13,872) Unfavourable step	▼ € 6,157
Equity	€ 283,191 Equity 2022: € 283,191 First fiscal year in the series	€ 223,361 Equity 2023: € 223,361 ▼ 21% vs 2022 (€ 283,191) Unfavourable step	€ 209,489 Equity 2024: € 209,489 ▼ 6% vs 2023 (€ 223,361) Unfavourable step	€ 189,459 Equity 2025: € 189,459 ▼ 10% vs 2024 (€ 209,489) Unfavourable step	▼ 10%
Total debts	€ 154,542 Total debts 2022: € 154,542 First fiscal year in the series	€ 178,588 Total debts 2023: € 178,588 ▲ 16% vs 2022 (€ 154,542) Unfavourable step	€ 124,604 Total debts 2024: € 124,604 ▼ 30% vs 2023 (€ 178,588) Favourable step	€ 141,743 Total debts 2025: € 141,743 ▲ 14% vs 2024 (€ 124,604) Unfavourable step	▲ 14%
Cash	€ 67,167 Cash 2022: € 67,167 First fiscal year in the series	€ 36,638 Cash 2023: € 36,638 ▼ 45% vs 2022 (€ 67,167) Unfavourable step	€ 7,729 Cash 2024: € 7,729 ▼ 79% vs 2023 (€ 36,638) Unfavourable step	€ 12,459 Cash 2025: € 12,459 ▲ 61% vs 2024 (€ 7,729) Favourable step	▲ 61%
Retained profit	€ 271,991 Retained profit 2022: € 271,991 First fiscal year in the series	€ 212,161 Retained profit 2023: € 212,161 ▼ 22% vs 2022 (€ 271,991) Unfavourable step	€ 198,289 Retained profit 2024: € 198,289 ▼ 7% vs 2023 (€ 212,161) Unfavourable step	€ 178,259 Retained profit 2025: € 178,259 ▼ 10% vs 2024 (€ 198,289) Unfavourable step	▼ 10%
Balance sheet total	€ 437,732 Balance sheet total 2022: € 437,732 First fiscal year in the series	€ 401,949 Balance sheet total 2023: € 401,949 ▼ 8% vs 2022 (€ 437,732) Unchanged	€ 334,093 Balance sheet total 2024: € 334,093 ▼ 17% vs 2023 (€ 401,949) Unchanged	€ 331,202 Balance sheet total 2025: € 331,202 ▼ 1% vs 2024 (€ 334,093) Unchanged	▼ 1%
Employees (FTE)	2.1 Employees (FTE) 2022: 2.1 First fiscal year in the series	2.1 Employees (FTE) 2023: 2.1 Unchanged (2.1) Unchanged	2.4 Employees (FTE) 2024: 2.4 ▲ 0.3 vs 2023 (2.1) Unchanged	2.3 Employees (FTE) 2025: 2.3 ▼ 0.1 vs 2024 (2.4) Unchanged	▼ 0.1

Key figures of GEASSOCIEERDE APOTHEEK EKEREN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GEASSOCIEERDE APOTHEEK EKEREN?

What happened at GEASSOCIEERDE APOTHEEK EKEREN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 A. Pirlot stepped down as director. NBB
2029 J. Mannaerts stepped down as director. NBB
Jul 28, 2026 New annual accounts for financial year 2025: loss of € 20,030. Source: NBB ↗
2023 A. Pirlot became a director. NBB
2023 J. Mannaerts became a director. NBB
Sep 25, 2001 New establishment in Antwerpen. KBO
Aug 31, 2001 Start of the company according to the CBE. KBO

In short

From € 54,791 loss in 2022 to € 20,030 loss in 2025.

On average € 61,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at GEASSOCIEERDE APOTHEEK EKEREN? We notify you, reason included.

Follow GEASSOCIEERDE APOTHEEK EKEREN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

AFS 66.7%

APOTHEEK VAN BROEKHOVEN 0.7%

The stake of AFS, APOTHEEK VAN BROEKHOVEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

GEASSOCIEERDE APOTHEEK EKEREN

AFS 0.1%

The shares are held by AFS (66.7%) and APOTHEEK VAN BROEKHOVEN (0.7%). It owns 0.1% of AFS itself.

See the full network in the app

Directors

According to the 2025 annual accounts

A. Pirlot

Director

Also active at: Apoteek't Groen Kruis, Sint-Gummarus Apotheek, AFS, Apotheek Clessens, Antwerp Port Pharmacy, APOTHEEK VAN BROEKHOVEN, GEASSOCIEERDE APOTHEEK VAN PUYVELDE, GEASSOCIEERDE APOTHEEK VERBIST +9 more

since 2023 · until 2029

J. Mannaerts

Director

Also active at: Geassocieerde Apotheek Plantijn, AFS, Apotheek Clessens, Antwerp Port Pharmacy, APOTHEEK VAN BROEKHOVEN, GEASSOCIEERDE APOTHEEK VAN PUYVELDE, GEASSOCIEERDE APOTHEEK VERBIST, Geassocieerde Apotheek Merelbeke +7 more

since 2023 · until 2029

Shareholders

AFS

66.7%

APOTHEEK VAN BROEKHOVEN

0.7%

Participations

AFS

0.1%

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpstraat 18

2180 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Vereniging van Mede-eigenaars van het gebouw te 2180 Antwerpen-Ekeren, Dorpstraat 18

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheeklaporte.be

Technologies

ApacheBootstrapDiviElementorFont AwesomeGoogle FontsLightboxPHPWP RocketWooCommerceWordPressYoast SEOjQueryjQuery UIlazysizesreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

A2HOSTING - A2 Hosting, Inc., US

Domain

apotheeklaporte.be

Registered

2016-02-08

Website info

HTTPS Ja

Languages EN

Features

Webshop Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number

0475.537.451

VAT number

BE 0475.537.451

Registered office

Dorpstraat 18, 2180 Antwerpen

Names & denominations

GEASSOCIEERDE APOTHEEK EKEREN · G.A. EKEREN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

31 August 2001

Peppol

Active · Active since 1 Jan 2001

Contact